Please provide your email address to receive an email when new articles are posted on . An AI model accurately distinguished cardiac amyloidosis from other phenotypic mimics. The model also showed ...
OXFORD, England, Jan. 10, 2024 /PRNewswire/ -- Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with ...
UChicago Medicine joined 17 other hospitals worldwide to validate and test the algorithm's results in a large and multiethnic patient population. They found that the AI tool demonstrated an accuracy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results